Skip to main navigation Skip to search Skip to main content

Phase 1 trial of navitoclax and sorafenib in patients with refractory solid tumors with a hepatocellular carcinoma expansion cohort.

  • Oluwadunni Eunice Emiloju
  • , Jun Yin
  • , Emily Koubek
  • , Joel M. Reid
  • , Mitesh Borad
  • , Yanyan Lou
  • , Mahesh Seetharam
  • , Martin Joseph Edelman
  • , Yixing Jiang
  • , Ahmed Omar Kaseb
  • , James Posey
  • , S. Lindsey Davis
  • , Gregory J. Gores
  • , Lewis R. Roberts
  • , Naoko Takebe
  • , Andrea Elisabeth Wahner Hendrickson
  • , Scott H. Kaufmann
  • , Joleen Hubbard
  • , Brian Addis Costello

Research output: Contribution to journal › Article › peer-review

1   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 trial of navitoclax and sorafenib in patients with refractory solid tumors with a hepatocellular carcinoma expansion cohort.'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science